CHINA SUNSINE CHEM HLDGS LTD (QES) fair value: what the stock is really worth
As of Oct 2, 2026: fair value of CHINA SUNSINE CHEM HLDGS LTD S$1.37, price S$0.62, upside +121.0%, quality 65 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch CHINA SUNSINE CHEM HLDGS LTD for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
China Sunsine Chemical Holdings Ltd., an investment holding company, manufactures and sells specialty chemicals in the People's Republic of China, rest of Asia, America, Europe, and internationally. The company operates through Rubber Chemicals, Heating Power, and Waste Treatment segments.
Show more
China Sunsine Chemical Holdings Ltd., an investment holding company, manufactures and sells specialty chemicals in the People's Republic of China, rest of Asia, America, Europe, and internationally. The company operates through Rubber Chemicals, Heating Power, and Waste Treatment segments. It offers rubber accelerators, anti-oxidant agents, anti-scorching agents, insoluble sulphur, and other rubber related products, such as tires, tubes, belts, shoes, rollers, cables, seals, latex products, and other light-color rubber products. The company provides its products under the Sunsine brand name. It is also involved in the production and supply of heating power; and waste treatment business. The company primarily serves the tire companies. China Sunsine Chemical Holdings Ltd. was founded in 1977 and is based in Singapore. China Sunsine Chemical Holdings Ltd. operates as a subsidiary of Success More Group Limited.
Stock analysis
CHINA SUNSINE CHEM HLDGS LTD (QES) currently trades at 0.6200 SGD, while our model-based Fair Value estimate is 1.37 SGD, implying the stock looks roughly 54.7% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 1.39 SGD per share, and 21 of the 22 models we run sit above the 0.6200 SGD price.
Bear case: the Asset-Based group reads lowest at 0.5900 SGD, and 1 of the 22 models stay below the price. Evidence for this calculation is low.
Scenario range: 1.03 SGD (bear) to 1.72 SGD (bull), the price of 0.6200 SGD sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 65/100 (solid quality), in the Basic Materials sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
CHINA SUNSINE CHEM HLDGS LTD reported revenue of 3.3B CNY in FY2025 versus 3.7B CNY in FY2021, a compound −3.2%/yr. Reported net income was 405M CNY in FY2025, compounding −5.4%/yr from FY2021.
Key figures
Market cap 591M SGD (≈ $462M) · P/E ratio 7.8 · P/S ratio 0.96 · EPS (TTM) 0.0800 SGD · Net margin 12.4% · Return on equity 9.4% · Return on assets (EBIT) 12.5% · Operating margin 15.3%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 22% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Basic Materials peers we cover trades at −39% fair-value upside, at 121%, QES screens cheaper than that median.
Fair Value models
Bear 1.03 SGDFair Value 1.37 SGDBull 1.72 SGD
Price 0.6200 SGD · Upside +121.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−6.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.0%
Start year 2020 (pandemic). Over 10 years: +5.8% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.8%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+1.3%
Earnings growth per share plus dividend.
Earnings per share, growth per year+1.3%
Dividend (yield on the price)0.0%
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 14%
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−16.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (figures in CNY, China: IMF forecast 1.7% a year to 2030, 1.4% from 2016 to 2025) that is about −18.2% a year for the price.
Compare CHINA SUNSINE CHEM HLDGS LTD with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Specialty Chemicals · 682 stocks
Beats the industry median on 13/13 measures
Overall it ranks above its industry peers.
Valuation
Quality Score65 · Top 25%
Fair Value upside+121.0% · Top 25%
Profitability
Return on equity (TTM)9.4% · Above median
Return on assets6.1% · Top 25%
Net margin (TTM)11.6% · Top 25%
Operating margin (TTM)15.3% · Top 25%
Growth and dividend
Revenue growth18.8% · Above median
Dividend yield (TTM)17.6% · Top 25%
Valuation Multiplesvs Specialty Chemicals median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is CHINA SUNSINE CHEM HLDGS LTD (QES) overvalued or undervalued?
As of Oct 2, 2026, our model estimates a fair value of 1.37 SGD versus a price of 0.6200 SGD, about +121% upside (undervalued).
What is the fair value of QES?
Our model-based fair value for CHINA SUNSINE CHEM HLDGS LTD is 1.37 SGD (as of Oct 2, 2026), built from audited fundamentals. The current price: 0.6200 SGD.
What is the quality score of QES?
CHINA SUNSINE CHEM HLDGS LTD has a Quality Score of 65/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for CHINA SUNSINE CHEM HLDGS LTD (QES)?
Our model-based price target is the fair value of 1.37 SGD (as of Oct 2, 2026) from 22 valuation models. Cautious scenario 1.03 SGD, optimistic scenario 1.72 SGD. It is a calculation from audited fundamentals, not an analyst target.
What is the CHINA SUNSINE CHEM HLDGS LTD stock forecast for 2026?
Our models put fair value at 1.37 SGD, about +121% upside versus a price of 0.6200 SGD (undervalued). Cautious scenario 1.03 SGD, optimistic scenario 1.72 SGD. The calculation is refreshed regularly with new filings.
What is the revenue of CHINA SUNSINE CHEM HLDGS LTD (QES)?
CHINA SUNSINE CHEM HLDGS LTD reported trailing-twelve-month revenue of about 3.6B CNY (latest available figure, as of Oct 2, 2026).
What growth is priced into CHINA SUNSINE CHEM HLDGS LTD (QES)?
For today's price to be fair in a discounted-cash-flow model, CHINA SUNSINE CHEM HLDGS LTD would have to grow free cash flow by -16.9 % per year for five years (discount rate 9.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +7.0 % per year. As of Oct 2, 2026.
What discount rate (WACC) does the fair value of QES use?
Our models discount CHINA SUNSINE CHEM HLDGS LTD at 9.6 %: a base by market capitalisation (small), damped by beta 0.25, country premium for Singapore. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For CHINA SUNSINE CHEM HLDGS LTD that is -16.9 % per year a year over ten years, using the same discount rate (9.6 %) and the same formula as our fair value.
How much growth has CHINA SUNSINE CHEM HLDGS LTD (QES) delivered so far?
Over the past 5 years revenue at CHINA SUNSINE CHEM HLDGS LTD grew +7.0 % a year. The price currently implies -16.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of CHINA SUNSINE CHEM HLDGS LTD (QES) growing?
The median revenue growth in the sector is +8.8 % a year. That is the yardstick for the growth priced into CHINA SUNSINE CHEM HLDGS LTD (-16.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of CHINA SUNSINE CHEM HLDGS LTD (QES)?
The free-cash-flow yield on the price is 12.19 %: that much free cash flow CHINA SUNSINE CHEM HLDGS LTD produces per unit of market value. When it exceeds the discount rate of our models (9.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of CHINA SUNSINE CHEM HLDGS LTD (QES)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For CHINA SUNSINE CHEM HLDGS LTD it is 1.37 SGD per share (as of Oct 2, 2026), against a price of 0.6200 SGD. It is the blended result of 22 valuation models (cash flow, earnings, asset, dividend).
Is CHINA SUNSINE CHEM HLDGS LTD stock overvalued or undervalued in 2026?
As of Oct 2, 2026, QES trades below its calculated fair value: price 0.6200 SGD, fair value 1.37 SGD, a gap of about +121% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of QES?
No. The price is what the market pays today (0.6200 SGD); the fair value is what the company's own numbers justify (1.37 SGD). For CHINA SUNSINE CHEM HLDGS LTD the two are 0.7500 SGD per share apart. That gap is exactly why we show both numbers side by side.
How much is CHINA SUNSINE CHEM HLDGS LTD worth?
The market values CHINA SUNSINE CHEM HLDGS LTD at about 591M SGD (market capitalisation, as of Oct 2, 2026). Per share that is 0.6200 SGD; our models calculate a fair value of 1.37 SGD per share.
What do the bullish and bearish scenarios say about QES?
Our models span a range for CHINA SUNSINE CHEM HLDGS LTD: cautious scenario 1.03 SGD, base 1.37 SGD, optimistic 1.72 SGD per share (as of Oct 2, 2026, price 0.6200 SGD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of QES?
CHINA SUNSINE CHEM HLDGS LTD trades at a price-to-earnings ratio of 7.8 (as of Oct 2, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 1.37 SGD is built from several models across several years. Other multiples: P/B 0.7, P/S 0.9, EV/EBITDA 1.2.
How solid is the balance sheet of CHINA SUNSINE CHEM HLDGS LTD (QES)?
Balance-sheet figures for CHINA SUNSINE CHEM HLDGS LTD (as of Oct 2, 2026): return on equity 9.4%. They feed the Quality Score of 65/100, which measures business quality independently of the share price.
How far is QES from its 52-week high?
CHINA SUNSINE CHEM HLDGS LTD trades at 0.6200 SGD, about 22% below its 52-week high of 0.7929 SGD and 5% above the low of 0.5911 SGD (as of Oct 2, 2026). Distance from the high says nothing about value: that is what the fair value of 1.37 SGD is for.
Which stocks are comparable to CHINA SUNSINE CHEM HLDGS LTD?
From the same area (Basic Materials) we also value Linde plc, The Sherwin-Williams Company, Ecolab Inc, Air Products and Chemicals, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is CHINA SUNSINE CHEM HLDGS LTD stock attractive at the current price?
The data as of Oct 2, 2026: price 0.6200 SGD, calculated fair value 1.37 SGD (+121%), Quality Score 65/100, from 22 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of QES calculated?
We run CHINA SUNSINE CHEM HLDGS LTD through 22 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 1.37 SGD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. CHINA SUNSINE CHEM HLDGS LTD currently trades 55 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of CHINA SUNSINE CHEM HLDGS LTD (QES)?
The closing price on Oct 2, 2026 was 0.6200 SGD. Our model-based fair value is 1.37 SGD, about +121% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with CHINA SUNSINE CHEM HLDGS LTD right now?
The price is below even our cautious bear case (1.03 SGD). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (65/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of CHINA SUNSINE CHEM HLDGS LTD
How large is the market capitalisation of CHINA SUNSINE CHEM HLDGS LTD (QES)?
The market capitalisation of CHINA SUNSINE CHEM HLDGS LTD is 591M SGD (≈ $462M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of CHINA SUNSINE CHEM HLDGS LTD (QES)?
The price-to-sales ratio of CHINA SUNSINE CHEM HLDGS LTD is 0.96 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of CHINA SUNSINE CHEM HLDGS LTD (QES)?
Earnings per share at CHINA SUNSINE CHEM HLDGS LTD are 0.0800 SGD (price ÷ EPS = P/E 7.8). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of CHINA SUNSINE CHEM HLDGS LTD (QES)?
The net margin of CHINA SUNSINE CHEM HLDGS LTD is 12.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of CHINA SUNSINE CHEM HLDGS LTD (QES)?
The return on equity (ROE) of CHINA SUNSINE CHEM HLDGS LTD is 9.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of CHINA SUNSINE CHEM HLDGS LTD (QES)?
On an EBIT basis the return on assets of CHINA SUNSINE CHEM HLDGS LTD is 12.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of CHINA SUNSINE CHEM HLDGS LTD (QES)?
The operating margin of CHINA SUNSINE CHEM HLDGS LTD is 15.3% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at CHINA SUNSINE CHEM HLDGS LTD (QES)?
Revenue at CHINA SUNSINE CHEM HLDGS LTD is growing +18.8% versus a year earlier (3y avg −5.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at CHINA SUNSINE CHEM HLDGS LTD (QES)?
Earnings per share at CHINA SUNSINE CHEM HLDGS LTD are growing +4.8% versus a year earlier. How much earnings per share grew versus a year earlier.
Free · no account needed
Watch CHINA SUNSINE CHEM HLDGS LTD in the live analysis
One click puts CHINA SUNSINE CHEM HLDGS LTD on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
